Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

Related Articles by Review for PubMed (Select 23362583)

1.
2.

Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis.

Venci JV, Gandhi MA.

Ann Pharmacother. 2013 Dec;47(12):1697-702. doi: 10.1177/1060028013509232. Epub 2013 Oct 23. Review. Erratum in: Ann Pharmacother. 2014 May;48(5):668. Dosage error in article text.

PMID:
24259625
3.

Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.

Linker RA, Gold R.

Curr Neurol Neurosci Rep. 2013 Nov;13(11):394. doi: 10.1007/s11910-013-0394-8. Review.

PMID:
24061646
4.

Dimethyl fumarate for multiple sclerosis.

Papadopoulou A, D'Souza M, Kappos L, Yaldizli O.

Expert Opin Investig Drugs. 2010 Dec;19(12):1603-12. doi: 10.1517/13543784.2010.534778. Epub 2010 Nov 11. Review.

PMID:
21067468
5.

Emerging oral drugs for multiple sclerosis.

Gasperini C, Cefaro LA, Borriello G, Tosto G, Prosperini L, Pozzilli C.

Expert Opin Emerg Drugs. 2008 Sep;13(3):465-77. doi: 10.1517/14728214.13.3.465 . Review.

PMID:
18764723
6.

Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.

Gold R.

CNS Drugs. 2011 Jan;25(1):37-52. doi: 10.2165/11539820-000000000-00000. Review.

PMID:
21128693
7.
8.

New oral drugs for multiple sclerosis.

Gasperini C, Ruggieri S.

Neurol Sci. 2009 Oct;30 Suppl 2:S179-83. doi: 10.1007/s10072-009-0146-3. Review.

PMID:
19882371
9.

Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis.

Stangel M, Linker RA.

Expert Rev Clin Pharmacol. 2013 Jul;6(4):355-62. doi: 10.1586/17512433.2013.811826. Review.

PMID:
23927662
10.

[FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].

Klatt J, Hartung HP, Hohlfeld R.

Nervenarzt. 2007 Oct;78(10):1200-8. Review. German.

PMID:
17668161
11.

Emerging oral therapies for multiple sclerosis.

Miller CE, Umhauer MA.

J Neurosci Nurs. 2011 Feb;43(1):3-14; quiz 15-6. Review.

PMID:
21338040
12.

Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.

Methner A, Zipp F.

Nat Rev Neurol. 2013 Feb;9(2):72-3. doi: 10.1038/nrneurol.2012.277. Epub 2013 Jan 22. Review. Erratum in: Nat Rev Neurol. 2013 May;9(5):240.

PMID:
23338282
13.

BG-12 in multiple sclerosis.

Phillips JT, Fox RJ.

Semin Neurol. 2013 Feb;33(1):56-65. doi: 10.1055/s-0033-1343796. Epub 2013 May 25. Review.

PMID:
23709213
14.

Oral fingolimod (gilenya) for multiple sclerosis.

[No authors listed]

Med Lett Drugs Ther. 2010 Dec 29;52(1353-1354):98-9. Review. No abstract available.

PMID:
21344782
15.

Drug evaluation: BG-12, an immunomodulatory dimethylfumarate.

Wakkee M, Thio HB.

Curr Opin Investig Drugs. 2007 Nov;8(11):955-62. Review.

PMID:
17979030
16.

Development of oral cladribine for the treatment of multiple sclerosis.

Hartung HP, Aktas O, Kieseier B, Giancarlo Comi GC.

J Neurol. 2010 Feb;257(2):163-70. doi: 10.1007/s00415-009-5359-0. Review.

PMID:
19921304
17.

Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies.

Linker RA, Lee DH, Stangel M, Gold R.

Expert Rev Neurother. 2008 Nov;8(11):1683-90. doi: 10.1586/14737175.8.11.1683. Review.

PMID:
18986239
18.

[Current treatment of multiple sclerosis].

Csépány T.

Lege Artis Med. 2011 Feb;21(2):97-104. Review. Hungarian.

PMID:
21710707
19.

Dimethyl fumarate : a Janus-faced substance?

Kees F.

Expert Opin Pharmacother. 2013 Aug;14(11):1559-67. doi: 10.1517/14656566.2013.804912. Epub 2013 May 22. Review.

PMID:
23697607
20.

Treatment options for multiple sclerosis: current and emerging therapies.

Gawronski KM, Rainka MM, Patel MJ, Gengo FM.

Pharmacotherapy. 2010 Sep;30(9):916-27. doi: 10.1592/phco.30.9.916. Review.

PMID:
20795847
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk